Select Page

Press Releases

Sign up to get full access to all our latest Press Releases

Acme Resources Announces Change of Name to Rapid Dose Therapeutics Corp. and Changes of Directors and Officers

December 10, 2018


Toronto, Burlington Ontario – Further to its press release of December 7, 2018, Rapid Dose Therapeutics Corp. (formerly ACME Resources Corp.) (“ACME” or the “Corporation”), is pleased to announce the change of its name from ACME Resources Corp. to Rapid Dose Therapeutics Corp. in connection...

Acme Resources and Rapid Dose Therapeutics Announce Completion of Amalgamation

December 7, 2018


Toronto, Burlington Ontario – ACME Resources Corp. (“ACME” or the “Corporation“) and Rapid Dose Therapeutics Inc. (“RDT”) are pleased to jointly announce the completion of the three-cornered amalgamation pursuant to an Amended and Restated Amalgamation Agreement (the “Amalgamation Agreement“) as of July 11, 2018 as...

Rapid Dose Therapeutics Announces Agreement With Chemesis International to License Quickstrip™ Technology in Puerto Rico

November 7, 2018


Toronto and Burlington, Canada, November 7, 2018 – ACME Resources Corp. (“ACME” or the “Company”) and Rapid Dose Therapeutics Inc. (“RDT”) are pleased to announce that RDT’s United States subsidiary, RDT Therapeutics Inc. (“RDT-US”), has signed an additional definitive five-year, renewable Managed Strip Services (MSS)...

Rapid Dose Therapeutics Signs an Exclusive Preferred Global Vendor Agreement With Aphria

November 5, 2018


Toronto, Burlington, Ontario – Monday, November 5, 2018 – ACME Resources Corp. (“ACME”) and Rapid Dose Therapeutics Inc. (“RDT”) are pleased to announce that RDT and Aphria Inc. (“Aphria”) (TSX: APHA and NYSE: APHA) have signed a definitive agreement granting Aphria exclusive preferred global vendor...

Rapid Dose Therapeutics Wins Top Ten in Grocery Award at Grocery Innovations Canada (GIC)

October 26, 2018


Toronto, Ontario – Friday, October 26, 2018 – Rapid Dose Therapeutics Inc. (“RDT”), a Canadian bio- technology company, providing disruptive proprietary drug delivery technologies for the nutraceutical, therapeutic and pharamecutical market is honoured to announce their product “QuickStrip™” won the highly respected “Top Ten in...

ACME Resources Announces Rapid Dose Therapeutics Signs A Definitive Agreement With Chemesis International

October 12, 2018


Toronto and Burlington, Canada, October 12, 2018 – ACME Resources Corp. (“ACME” or the “Company”) and Rapid Dose Therapeutics Inc. (“RDT”), a bio-technology company focused on innovative drug delivery solutions designed to improve patient outcomes, announced today, that RDT’s United States subsidiary, RDT Therapeutics Inc....

Acme Resources and Rapid Dose Therapeutics Announce Filing of Defence in Court Proceeding Commenced Against Rapid Dose Therapeutics

October 10, 2018


Toronto and Burlington, Ontario–(Newsfile Corp. – October 10, 2018) – ACME Resources Corp. (“ACME” or the “Company”) and Rapid Dose Therapeutics Inc. (“RDT”) announce that RDT has filed its Statement of Defence in response to legal proceedings commenced against RDT in the Ontario Superior Court...

Aphria and Rapid Dose Therapeutics Sign MOU to Bring Innovative QuickStrip™ Oral Thin Strips to Aphria’s Portfolio of Medical and Adult-Use Brands

September 5, 2018


Leamington and Burlington, Ontario – September 5, 2018 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH and US OTC: APHQF) and Rapid Dose Therapeutics Inc. (“RDT”), a Canadian bio-technology company focused on innovative drug delivery solutions, announced today that they have signed a non-binding...

UNLV And Rapid Dose Therapeutics Conduct Novel Research to Evaluate Innovative Quickstrip™ Oral Thin Strips

August 20, 2018


Las Vegas, Nevada and Burlington, Ontario – August 20, 2018 – University of Las Vegas (“UNLV”) and Rapid Dose Therapeutics Inc.(“RDT”) (CSE: DOSE), a Canadian bio-technology company focused on innovative drug delivery solutions, announced today that they have signed a research agreement related to RDT’s...

ACME Resources and Rapid Dose Therapeutics Proceed to Shareholder Meetings to Approve Their Proposed Merger and Provide Update on Scientific Research

August 13, 2018


Toronto and Burlington, Canada, August 13, 2018 – ACME Resources Corp. (“ACME” or the “Company”) and Rapid Dose Therapeutics Inc. (“RDT”) are pleased to announce that ACME has mailed the Notice and Management Information Circular for its shareholders meeting scheduled for August 30, 2018 and...

1 2